Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Oncocyte Corp (OCX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 05/02/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/11/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/30/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 03/19/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 04/28/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
| 03/25/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 04/30/2019 |
10-K/A
| Annual Report for the period ended December 31, 2018 [amend] |
| 04/01/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 04/30/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
| 04/02/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 02/27/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 05/24/2016 |
10-K/A
| Annual Report for the period ended December 31, 2015 [amend] |
| 03/30/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
|
|